ITMI911432A0 - Steroidi 3-carbossi 17b - sostituiti insaturi - Google Patents

Steroidi 3-carbossi 17b - sostituiti insaturi

Info

Publication number
ITMI911432A0
ITMI911432A0 IT91MI1432A ITMI911432A ITMI911432A0 IT MI911432 A0 ITMI911432 A0 IT MI911432A0 IT 91MI1432 A IT91MI1432 A IT 91MI1432A IT MI911432 A ITMI911432 A IT MI911432A IT MI911432 A0 ITMI911432 A0 IT MI911432A0
Authority
IT
Italy
Prior art keywords
steroids
carboxy
unsaturated substituted
unsaturated
substituted
Prior art date
Application number
IT91MI1432A
Other languages
English (en)
Inventor
Achille Panzeri
Marcella Nesi
Salle Enrico Di
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of ITMI911432A0 publication Critical patent/ITMI911432A0/it
Priority to ITMI911432A priority Critical patent/IT1259419B/it
Priority to YU52992A priority patent/YU52992A/sh
Priority to MYPI92000863A priority patent/MY131089A/en
Priority to IL10194792A priority patent/IL101947A/en
Priority to NZ242850A priority patent/NZ242850A/en
Priority to US07/886,574 priority patent/US5212166A/en
Priority to CA002087953A priority patent/CA2087953A1/en
Priority to EP92910992A priority patent/EP0540717B1/en
Priority to EP92108670A priority patent/EP0517047A1/en
Priority to CZ93265A priority patent/CZ281309B6/cs
Priority to TW081104019A priority patent/TW213467B/zh
Priority to JP50978992A priority patent/JP3226919B2/ja
Priority to MX9202438A priority patent/MX9202438A/es
Priority to DE69221074T priority patent/DE69221074T2/de
Priority to ES92910992T priority patent/ES2106185T3/es
Priority to RU93004939A priority patent/RU2104283C1/ru
Priority to ZA923758A priority patent/ZA923758B/xx
Priority to PCT/EP1992/001153 priority patent/WO1992020700A1/en
Priority to AT92910992T priority patent/ATE155792T1/de
Priority to IDP308292A priority patent/ID954B/id
Priority to HU9300176A priority patent/HUT64083A/hu
Priority to DK92910992.4T priority patent/DK0540717T3/da
Priority to AU17781/92A priority patent/AU655280B2/en
Priority to CN92103919A priority patent/CN1035055C/zh
Priority to IE163492A priority patent/IE921634A1/en
Publication of ITMI911432A1 publication Critical patent/ITMI911432A1/it
Priority to FI930277A priority patent/FI930277A0/fi
Priority to NO93930244A priority patent/NO930244L/no
Application granted granted Critical
Publication of IT1259419B publication Critical patent/IT1259419B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0066—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by a carbon atom forming part of an amide group

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Details Of Garments (AREA)
  • Ceramic Products (AREA)
  • Dental Preparations (AREA)
  • Medicines Containing Plant Substances (AREA)
ITMI911432A 1991-05-24 1991-05-24 Steroidi 3-carbossi 17b - sostituiti insaturi utili come inibitori della testosterone 5 a reduttasi IT1259419B (it)

Priority Applications (27)

Application Number Priority Date Filing Date Title
ITMI911432A IT1259419B (it) 1991-05-24 1991-05-24 Steroidi 3-carbossi 17b - sostituiti insaturi utili come inibitori della testosterone 5 a reduttasi
YU52992A YU52992A (sh) 1991-05-24 1992-05-20 Nezasićeni 17 beta-supstituisani 3-karboksi steroidi
MYPI92000863A MY131089A (en) 1991-05-24 1992-05-20 Unsaturated 17(beta)-substituted 3-carboxy steroids
IL10194792A IL101947A (en) 1991-05-24 1992-05-21 Unsaturated 3-carboxy-steroids in 71-Transformed preparation and pharmaceutical preparations containing
NZ242850A NZ242850A (en) 1991-05-24 1992-05-21 17-carbamoyl androstane derivatives; medicaments, use, and methods of
US07/886,574 US5212166A (en) 1991-05-24 1992-05-21 Unsaturated 17β-subsituted 3-carboxy steroids
ES92910992T ES2106185T3 (es) 1991-05-24 1992-05-22 3-carboxiesteroides 17-beta-sustituidos no saturados.
PCT/EP1992/001153 WO1992020700A1 (en) 1991-05-24 1992-05-22 UNSATURATED 17β-SUBSTITUTED 3-CARBOXY STEROIDS
EP92108670A EP0517047A1 (en) 1991-05-24 1992-05-22 Unsaturated 17beta-substituted 3-carboxy steroids
CZ93265A CZ281309B6 (cs) 1991-05-24 1992-05-22 Nenasycené 17beta-substituované 3-karboxy-steroidy
TW081104019A TW213467B (it) 1991-05-24 1992-05-22
JP50978992A JP3226919B2 (ja) 1991-05-24 1992-05-22 不飽和の１７β―置換―３―カルボキシステロイド
MX9202438A MX9202438A (es) 1991-05-24 1992-05-22 Esteroides 3-carboxi insaturados substituidos en la posicion 17 beta, procedimiento para su preparacion y composicion farmaceutica que los contiene.
DE69221074T DE69221074T2 (de) 1991-05-24 1992-05-22 Ungesatigte 17-beta-substituierte-3-carboxy steroide
CA002087953A CA2087953A1 (en) 1991-05-24 1992-05-22 Unsaturated 17.beta. -substituted 3-carboxy steroids
RU93004939A RU2104283C1 (ru) 1991-05-24 1992-05-22 17бета-замещенные 3-карбоксистероиды, способ их получения, фармкомпозиция
ZA923758A ZA923758B (en) 1991-05-24 1992-05-22 Unsaturated 17-substituted 3-carboxy steroids
EP92910992A EP0540717B1 (en) 1991-05-24 1992-05-22 UNSATURATED 17$g(b)-SUBSTITUTED 3-CARBOXY STEROIDS
AT92910992T ATE155792T1 (de) 1991-05-24 1992-05-22 Ungesatigte 17-beta-substituierte-3-carboxy steroide
IDP308292A ID954B (id) 1991-05-24 1992-05-22 STEROID 3-KARBOKSI TERSUBSTITUSI-17β TAK JENUH
HU9300176A HUT64083A (en) 1991-05-24 1992-05-22 Process for producing unsaturated, 17beta-substituted 3-carboxy steroids and pharmaceutical compositions comprising same as active ingredient
DK92910992.4T DK0540717T3 (da) 1991-05-24 1992-05-22 Umættede 17 beta-substituerede 3-carboxysteroider
AU17781/92A AU655280B2 (en) 1991-05-24 1992-05-22 Unsaturated 17beta -substituted 3-carboxy steroids
CN92103919A CN1035055C (zh) 1991-05-24 1992-05-23 不饱和的17β-取代的3-羧基甾族化合物的制备方法
IE163492A IE921634A1 (en) 1991-05-24 1992-07-01 UNSATURATED 17ß-SUBSTITUTED 3-CARBOXY STEROIDS
FI930277A FI930277A0 (fi) 1991-05-24 1993-01-22 Omaettade 17b-substituerade 3-karboxisteroider
NO93930244A NO930244L (no) 1991-05-24 1993-01-25 Umettede 17beta-substituerte 3-karboksysteroider

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI911432A IT1259419B (it) 1991-05-24 1991-05-24 Steroidi 3-carbossi 17b - sostituiti insaturi utili come inibitori della testosterone 5 a reduttasi

Publications (3)

Publication Number Publication Date
ITMI911432A0 true ITMI911432A0 (it) 1991-05-24
ITMI911432A1 ITMI911432A1 (it) 1992-11-24
IT1259419B IT1259419B (it) 1996-03-18

Family

ID=11359980

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI911432A IT1259419B (it) 1991-05-24 1991-05-24 Steroidi 3-carbossi 17b - sostituiti insaturi utili come inibitori della testosterone 5 a reduttasi

Country Status (26)

Country Link
US (1) US5212166A (it)
EP (2) EP0517047A1 (it)
JP (1) JP3226919B2 (it)
CN (1) CN1035055C (it)
AT (1) ATE155792T1 (it)
AU (1) AU655280B2 (it)
CA (1) CA2087953A1 (it)
CZ (1) CZ281309B6 (it)
DE (1) DE69221074T2 (it)
DK (1) DK0540717T3 (it)
ES (1) ES2106185T3 (it)
FI (1) FI930277A0 (it)
HU (1) HUT64083A (it)
ID (1) ID954B (it)
IE (1) IE921634A1 (it)
IL (1) IL101947A (it)
IT (1) IT1259419B (it)
MX (1) MX9202438A (it)
MY (1) MY131089A (it)
NO (1) NO930244L (it)
NZ (1) NZ242850A (it)
RU (1) RU2104283C1 (it)
TW (1) TW213467B (it)
WO (1) WO1992020700A1 (it)
YU (1) YU52992A (it)
ZA (1) ZA923758B (it)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ252866A (en) * 1992-04-30 1996-09-25 Smithkline Beecham Corp 17-acyl-estra-1,3,5(10)-triene-3-carboxylic acids; precursors
US5683995A (en) * 1992-11-18 1997-11-04 Smithkline Beecham Corporation 17 substituted acyl-3-carboxy 3,5-diene steroidals as α-reductase inhibitors
US5641765A (en) * 1992-11-18 1997-06-24 Smithkline Beecham Corporation 17-αand 17-βsubstituted acyl-3-carboxy-3,5-dienes and use in inhibiting 5-α-reductase
ATE227122T1 (de) * 1993-09-03 2002-11-15 Smithkline Beecham Corp Stabilisierte tablettenformulierung
GB9324371D0 (en) * 1993-11-26 1994-01-12 Erba Carlo Spa Side chain fluoro substituted 3-carboxysteroids
US5430157A (en) * 1993-12-13 1995-07-04 Eli Lilly And Company Reduced phenanthrenes
GB9402041D0 (en) * 1994-02-03 1994-03-30 Smithkline Beecham Corp Compounds
US5714480A (en) * 1994-03-31 1998-02-03 Smithkline Beecham Corporation Treating cardiovascular disease with steroidal 5-alpha-reductase inhibitors
WO1995028413A1 (en) * 1994-04-15 1995-10-26 Smithkline Beecham Corporation 17β-SUBSTITUTED 3-CARBOXY STEROIDS THAT INHIBIT 5-α-REDUCTASE
GB9415183D0 (en) * 1994-07-28 1994-09-21 Erba Carlo Spa 3-carboxysteroids with a fluorinated side-chain
US5543417A (en) * 1994-10-21 1996-08-06 Merck & Co., Inc. Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
DE69942578D1 (de) 1998-05-22 2010-08-26 Univ R Bifunktionelle moleküle sowie darauf basierende therapien.
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
NZ616673A (en) 2009-02-20 2014-08-29 To Bbb Holding B V Glutathione-based drug delivery system
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5041433A (en) * 1987-04-29 1991-08-20 Smithkline Beecham Corporation 11-keto or hydroxy 3,5-diene steroids as inhibitors of steriod 5-α-reductase
US4910226A (en) * 1987-04-29 1990-03-20 Smithkline Beckman Corporation Steroid 5-alpha-reductase inhibitors
US5032586A (en) * 1989-08-24 1991-07-16 Smithkline Beecham Corporation 7-keto or hydroxy 3,5-diene steroids as inhibitors of steroid 5-alpha reductase
US5091380A (en) * 1990-06-28 1992-02-25 Merck & Co., Inc. N-monosubstituted adamantyl/norbornanyl 17β-carbamides of 3-carboxy-androst-3,5-dienes as testosterone 5α-reductase inhibitors
DK0567271T3 (da) * 1992-04-20 1998-02-16 Sankyo Co Steroidderivater til behandling af prostatahypertrofi, fremgangsmåde til fremstilling heraf og anvendelser heraf

Also Published As

Publication number Publication date
AU655280B2 (en) 1994-12-15
ES2106185T3 (es) 1997-11-01
US5212166A (en) 1993-05-18
EP0540717B1 (en) 1997-07-23
TW213467B (it) 1993-09-21
YU52992A (sh) 1995-03-27
RU2104283C1 (ru) 1998-02-10
CN1067057A (zh) 1992-12-16
ATE155792T1 (de) 1997-08-15
FI930277A (fi) 1993-01-22
HU9300176D0 (en) 1993-04-28
EP0540717A1 (en) 1993-05-12
DE69221074T2 (de) 1997-11-13
MX9202438A (es) 1992-11-01
MY131089A (en) 2007-07-31
IE921634A1 (en) 1992-12-02
IT1259419B (it) 1996-03-18
DE69221074D1 (de) 1997-09-04
ID954B (id) 1996-09-25
CA2087953A1 (en) 1992-11-25
CN1035055C (zh) 1997-06-04
JPH06500342A (ja) 1994-01-13
EP0517047A1 (en) 1992-12-09
IL101947A (en) 1996-01-19
NZ242850A (en) 1994-01-26
NO930244D0 (no) 1993-01-25
DK0540717T3 (da) 1997-08-18
FI930277A0 (fi) 1993-01-22
AU1778192A (en) 1992-12-30
ITMI911432A1 (it) 1992-11-24
NO930244L (no) 1993-01-27
CZ281309B6 (cs) 1996-08-14
ZA923758B (en) 1993-01-27
HUT64083A (en) 1993-11-29
JP3226919B2 (ja) 2001-11-12
WO1992020700A1 (en) 1992-11-26
CZ26593A3 (en) 1993-11-17

Similar Documents

Publication Publication Date Title
FI933243A0 (fi) Foerfarande foer framstaellning av pultruderad panel
FI923289A (fi) Trifluormetylbensylfosfonat anvaendbara vid behandling av osteoporos
FI925341A0 (fi) Uppvaermbar provtagningssond foer vaetskor vid en automatiserad provtagningsanordning
FI921792A (fi) Drivanordning foer ledstaong vid persontransportoer
NO931117D0 (no) Steroidderivater
ITMI911432A0 (it) Steroidi 3-carbossi 17b - sostituiti insaturi
ATE172738T1 (de) Substituierte 6-aza-androstenone
NO952289D0 (no) Substituerte benzazepinoner
DE69320177T2 (de) Vorhang
NO920420L (no) 3-quinuklidin-derivater
FI934447A0 (fi) Nytt immunhaemmande aemne fraon strptomyces braegensis
FI925720A (fi) Hydrauliskt spaenningsystem vid passagerar transportoerer
DE69221613T2 (de) Former
DE59309389D1 (de) Substituierte Thiophencarbonsäureamide
TR25953A (tr) SüBSTITüE EDILMIS 2-ARILPIROLLER
FI934935A (fi) Maetcell foer elektrokinetisk potential
FI933854A (fi) Anordning vid en saog
DE59310082D1 (de) Substituierte 2-arylpyrrole
TR26694A (tr) SüBSTITüE EDILMIS 4-HETARIL-PIRAZOLINLER
KR940007064U (ko) 커텐 개폐장치
NO932638D0 (no) 21-klor-pregnanderivat
BR7100850U (pt) Painel
SE9300030D0 (sv) Novel colon- or ileum-specific steroid derivatives
BR7101509U (pt) Painel protetor
BR9104443A (pt) Aperfeicoamento em esfero-movel

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970506